BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15465153)

  • 1. Stable overall referral rates of primary radiotherapy for newly diagnosed cancer patients in the ageing population of South-Eastern Netherlands, 1975-1998.
    Lybeert ML; Louwman M; Coebergh JW
    Radiother Oncol; 2004 Oct; 73(1):101-8. PubMed ID: 15465153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988-2002.
    Vulto A; Louwman M; Rodrigus P; Coebergh JW
    Radiother Oncol; 2006 Feb; 78(2):131-7. PubMed ID: 16443297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based study of trends and variations in radiotherapy as part of primary treatment of cancer in the southern Netherlands between 1988 and 2006, with an emphasis on breast and rectal cancer.
    Vulto JC; Lybeert ML; Louwman MW; Poortmans PM; Coebergh JW
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):464-71. PubMed ID: 19289268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.
    Vulto AJ; Lemmens VE; Louwman MW; Janssen-Heijnen ML; Poortmans PH; Lybeert ML; Coebergh JW
    Cancer; 2006 Jun; 106(12):2734-42. PubMed ID: 16703598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital variation in referral for primary radiotherapy in South Netherlands, 1988-1999.
    Vulto JC; Louwman WJ; Poortmans PM; Coebergh JW
    Eur J Cancer; 2005 Nov; 41(17):2722-7. PubMed ID: 16242315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based study of radiotherapy in a cohort of patients with rectal cancer diagnosed between 1996 and 2000.
    Vulto JC; Louwman WJ; Lybeert ML; Poortmans PM; Rutten HJ; Brenninkmeijer SJ; Coebergh JW
    Eur J Surg Oncol; 2007 Oct; 33(8):993-7. PubMed ID: 17400420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trends in the use of primary radiotherapy for cancer in the Netherlands in patients with breast, prostate, rectal and lung tumours].
    Struikmans H; Aarts MJ; Jobsen JJ; Koning CC; Poortmans PM; Louwman MW; Coebergh JW
    Ned Tijdschr Geneeskd; 2012; 156(12):A4426. PubMed ID: 22436526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General practitioners and referral for palliative radiotherapy: a population-based survey.
    Vulto A; van Bommel M; Poortmans P; Lybeert M; Louwman M; Baart R; Coebergh JW
    Radiother Oncol; 2009 May; 91(2):267-70. PubMed ID: 19321216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
    Benitez PR; Chen PY; Vicini FA; Wallace M; Kestin L; Edmundson G; Gustafson G; Martinez A
    Am J Surg; 2004 Oct; 188(4):355-64. PubMed ID: 15474426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast cancer from 1997 till 2008: a population-based study in the Netherlands.
    Struikmans H; Aarts MJ; Jobsen JJ; Koning CC; Merkus JW; Lybeert ML; Immerzeel J; Poortmans PM; Veerbeek L; Louwman MW; Coebergh JW
    Radiother Oncol; 2011 Aug; 100(2):320-5. PubMed ID: 21640419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study.
    Hooning MJ; Aleman BM; van Rosmalen AJ; Kuenen MA; Klijn JG; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1081-91. PubMed ID: 16446057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population based study of radiotherapy in a cohort of patients with breast cancer diagnosed between 1996 and 2000.
    Vulto JC; Louwman WJ; Poortmans PM; Lybeert LM; Rutten HJ; Coebergh JW
    Eur J Cancer; 2007 Sep; 43(13):1976-82. PubMed ID: 17618112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
    Vermaas M; Gosselink MP; Ferenschild FT; van den Aardweg E; Lont HE; Kemperman HW; van der Harst E; Tetteroo GW; Oostenbroek RJ; Dijkhuis CM; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
    Klenova A; Parvanova V; Georgiev R; Gesheva N
    J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.
    Loftås P; Onnesjö S; Widegren E; Adell G; Kayed H; Kleeff J; Zentgraf H; Sun XF
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):137-42. PubMed ID: 19289258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trends in the incidence and death from cancer from 1989-2003 in The Netherlands].
    Siesling S; Visser O; van Dijck JA; Coebergh JW
    Ned Tijdschr Geneeskd; 2006 Nov; 150(45):2490-6. PubMed ID: 17137098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of primary radiotherapy for rectal cancer in the Netherlands between 1997 and 2008: a population-based study.
    Jobsen JJ; Aarts MJ; Siesling S; Klaase J; Louwman WJ; Poortmans PM; Lybeert ML; Koning CC; Struikmans H; Coebergh JW
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e1-8. PubMed ID: 21968247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
    Taghian AG; Assaad SI; Niemierko A; Floyd SR; Powell SN
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):386-91. PubMed ID: 15890579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.